semaglutide plushcare GLP-1 Review: Clinical Context & Options – PlexusDx The Wegovy® Shortage and Alternative

Most patients begin experiencing noticeable appetite suppression within one to four weeks of starting semaglutide, a GLP-1 receptor agonist FDA-approved for chronic weight management and type 2 diabetes

Combining weight loss medications with healthy lifestyle changes can make a noticeable difference in managing PCOS symptoms

10.5414/cnp65380 Clin Nephrol

The liquid format may be easier to consume during periods of nausea, and the controlled portion size prevents overwhelming an already compromised digestive system

They work by slowing digestion, reducing hunger, and improving insulin sensitivity, leading to significant weight lossoften 10-20% of body weight in clinical trials